Method for preparing granules
11844864 · 2023-12-19
Assignee
Inventors
- Markus Krumme (Allschwil, CH)
- Hans de Waard (Basel, CH)
- Klaus-Peter MOLL (Basel, CH)
- Adrian Schmidt (Weil am Rhein, DE)
- Julien Taillemite (Huningue, FR)
Cpc classification
A61K9/1635
HUMAN NECESSITIES
A61K31/192
HUMAN NECESSITIES
A61K9/1694
HUMAN NECESSITIES
A61K9/0053
HUMAN NECESSITIES
A61K9/1652
HUMAN NECESSITIES
A61K9/2054
HUMAN NECESSITIES
International classification
A61K9/16
HUMAN NECESSITIES
A61K31/192
HUMAN NECESSITIES
A61K9/00
HUMAN NECESSITIES
Abstract
A method for preparing granules. A slurry containing solid API powder particles dispersed in a liquid is prepared. The slurry is fed to a granulator and mixed with a dry base powder within the granulator in order to produce a slurry/base powder mixture. The slurry/base powder mixture produced within the granulator is dried in order to obtain granules containing the solid API particles and the base powder.
Claims
1. A method for preparing granules, the method comprising: i. preparing a slurry containing solid active pharmaceutical ingredient (API) powder particles dispersed in a liquid, ii. feeding the slurry to a continuous granulator, iii. mixing the slurry with a dry base powder within the continuous granulator in order to produce a slurry/base powder mixture, wherein at least the mixing step is conducted at a temperature less than about 20° C.; and iv. drying the slurry/base powder mixture produced within the continuous granulator, wherein the slurry/base powder mixture exiting the continuous granulator is dried by means of a continuous or semi-continuous dryer, wherein a drying temperature for drying the slurry/base powder mixture is between 30 and 100° C., and wherein the resulting granules comprise the solid API particles and the base powder.
2. The method according to claim 1, wherein the dry base powder is fed to the continuous granulator at a first feeding port and the slurry is fed to the continuous granulator at a second feeding port which is arranged downstream of the first feeding port, the second feeding port comprising a feeding nozzle.
3. The method according to claim 1, wherein the continuous granulator has at least one extruder screw.
4. The method according to claim 3, wherein at least one extruder screw comprises at least one of: a base powder supply zone for conveying the dry base powder into an extruder housing, the base powder supply zone of the extruder screw having a first pitch; a first compression zone for conveying and densifying the dry base powder, the first compression zone being arranged downstream of the base powder supply zone and having a second pitch which is smaller than the first pitch; a first granulation zone for kneading the slurry with the dry base powder, the first granulation zone being arranged downstream of the first compression zone; a second compression zone for conveying and densifying the slurry/base powder mixture, the second compression zone being arranged downstream of the first granulation zone; a second granulation zone for kneading the slurry with the dry base powder, the second granulation zone being arranged downstream of the second compression zone; a third compression zone for conveying and densifying the slurry/base powder mixture, the third compression zone being arranged downstream of the second granulation zone, and a homogenization zone for homogenizing the slurry/base powder mixture, the homogenizing zone being arranged downstream of the third compression zone.
5. The method according to claim 1, wherein the liquid contained in the slurry contains a synthesizing liquid used for synthesizing the solid API powder particles in a preceding API synthesizing step or the liquid contained in the slurry contains a washing liquid used for washing the solid API powder particles in a preceding washing step.
6. The method according to claim 1, wherein the liquid contained in the slurry contains water and at least one organic solvent selected from ethanol, methanol, isopropanol and ethylacetate, or the liquid contained in the slurry contains water or at least one organic solvent selected from ethanol, methanol, isopropanol and ethylacetate.
7. The method according to claim 1, wherein the dry base powder contains a binder.
8. The method according to claim 7, wherein the dry base powder consists of a binder or wherein the dry base powder consists of a powder pre-blend containing a binder, and/or wherein the dry base powder contains solid API powder particles.
9. The method according to claim 1, wherein the dry base powder comprises at least one of API, lactose, cellulose, microcrystalline cellulose, sodium carboxymethyl cellulose, glyceryl behenate, magnesium stearate, sodium stearyl fumarate, polyvinylpyrrolidone, and calcium phosphate.
10. The method according to claim 1, wherein the slurry is fed to the continuous granulator by means of a metered pump.
11. The method according to claim 1, wherein the dry base powder is fed to the continuous granulator by means of a powder dosing device which is controlled in dependence on a weight change of a reserve of the dry base powder contained in a reservoir of the powder dosing device.
12. The method according to claim 1, wherein the API contains at least one of ibuprofen, lumefantrine and LDK378.
13. A method for manufacturing solid oral dosage forms, wherein the method comprises: i. preparing granules in accordance with the method according to claim 1, and ii. compacting the granules so as to form tablets or filling the granules into capsules.
14. The method according to claim 1, wherein the liquid contained in the slurry comprises a synthesizing liquid used for synthesizing the solid API powder particles or a washing liquid used for washing the solid API powder particles.
15. The method according to claim 1, wherein a maximum temperature in any zone throughout the process is no greater than 75° C.
Description
(1) Preferred embodiments of the invention now will be described in greater detail with reference to the appended schematic drawings and examples, wherein:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10) Furthermore, a dry base powder 14 is provided. The base powder 14 contains a binder for powder agglomaration, for example polyvinylpyrrolidone. A selected binder may constitute the only component of the base powder 14. It is, however, also conceivable that the base powder 14 is a binder mixture or a binder containing powder pre-blend, i.e. a binder mixture or a binder containing powder mixture which is prepared in a preceding mixing step. Lactose and/or cellulose, in particular microcrystalline cellulose, may be added so as to serve as tablet binders/diluents. Glyceryl behenate, magnesium stearate, and/or sodium stearyl fumarate may be added as lubricants. Sodium carboxymethyl cellulose may be added as a disintegrant. Further, the dry base powder may contain or consist of solid API powder particles. In particular, the dry base powder may contain powder particles of the same API that is also contained in the slurry fed to the granulator.
(11) As becomes apparent from
(12) In the arrangement depicted in
(13) The slurry 12 is fed to the granulator 16 at a second feeding port 26 which, with respect to the conveying direction C, is arranged downstream of the first feeding port 18. In particular, the slurry 12 is fed to the granulator 16 by means of a metered pump 28. In dependence on the type of the API and the properties of the API powder such as, for example, particle size, particle size distribution, surface properties, wetting properties, etc., a concentration of the API within the suspension may be between 10 to 70 weight %. For example, when using ibuprofen as the API, the concentration of the API within the suspension may be between 29 to 53 weight %, when using lumefantrine as the API, the concentration of the API within the suspension may be between 25 to 35 weight %, and when using Opadry yellow as a model API, the concentration of the model API within the suspension may be between 10 to 20 weight %. In any case, in order to ensure a reliable continuous volumetric dosing of the slurry 12 to the granulator 16, the concentration of the API within the suspension, i.e. a liquid/solid ratio within the slurry 12 and a viscosity of the slurry 12 should be appropriately adjusted, if needed by means of the addition of solid or liquid additives to the slurry 12, in order to allow an unhindered pumping of the slurry 12 into the granulator 16.
(14) A feed rate of the dry base powder 14 to the granulator 16 may vary in dependence on the flow properties of the powdery dry base powder 14, the API load of the slurry 12, i.e. the liquid/solid ratio within the slurry 12, the viscosity of the slurry 12, the liquid/solid ratio within a slurry/base powder mixture 30, the viscosity of the slurry/base powder mixture 30, the wetting behavior of the dry base powder 14 with the liquid contained in the slurry 12, etc. Typical feed rates of the dry base powder 14 to a small scale granulator 16 may vary between 140 and 500 g/h, whereas typical slurry feed rates to the small scale granulator 16 may vary between 200 and 1000 g/h. Typical feed rates to a medium scale granulator with a 16 mm diameter screw may be up to 10 times higher and typical feed rates to a large scale granulator with a 47 mm diameter screw may be up to 50 kg/h.
(15) Within the granulator 16, the slurry 12 is mixed with the dry base powder 14 in order to produce a slurry/base powder mixture 30 exiting the granulator 16 at an outlet port 32. A detailed view of the granulator 16 is depicted in
(16) Further, the extruder screws 24 comprise a first compression zone 38 for conveying and densifying the dry base powder supplied into the extruder housing 36 via the first feeding port 18. The first compression zone 38 of the extruder screws 24 is arranged downstream of the base powder supply zone 34, ends in a region of the second feeding port 26 and has a second pitch P2 which is smaller than the first pitch P1. A detailed view, i.e. a detailed side view and a cross-sectional view, of the design of the extruder screws 24 in the first compression zone 38 is depicted in
(17) Downstream of the first compression zone 38 and more or less immediately downstream of the second feeding port 26 the extruder screws 24 comprise a first granulation zone 40 for kneading the slurry with the dry base powder. A detailed view, i.e. a detailed side view and a cross-sectional view, of the design of the extruder screws 24 in the first granulation zone 40 is depicted in
(18) In addition, the extruder screws 24, downstream of the first granulation zone 40, are provided with a second compression zone 42 wherein the extruder screws 24, in the exemplary embodiment of a granulator 16 shown in the drawings, have a pitch that is equal to the second pitch P2 of the extruder screws 24 in the first compression zone 38 and the design of the extruder screws 24 corresponds to the design of the extruder screws 24 in the first compression zone 38 as depicted in
(19) Further, the extruder screws 24 comprise a second granulation zone 44 for further kneading the slurry with the dry base powder. The second granulation zone 44 is arranged downstream of the second compression zone 42. A detailed view, i.e. a detailed side view and a cross-sectional view, of the design of the extruder screws 24 in the second granulation zone 44 is depicted in
(20) A third compression zone 46 for further conveying and densifying the slurry/base powder mixture is provided on the extruder screws 24 downstream of the second granulation zone 44. In the third compression zone 46, the extruder screws 24 have a pitch that is equal to the second pitch P2 of the extruder screws 24 in the first compression zone 38 and the design of the extruder screws 24 corresponds to the design of the extruder screws 24 in the first compression zone 38 as depicted in
(21) Finally, although the slurry/base powder mixture should already be homogenized upon exiting the second granulation zone 44, the extruder screws 24 are provided with a homogenization zone 48 for further homogenizing the slurry/base powder mixture. In particular, the homogenizing zone 48 is arranged downstream of the third compression zone 46 and the extruder screws 24, in the homogenizing zone 48, are designed in the form of a distributive feed screw which provides for a final homogenization of the slurry/base powder mixture prior to exiting the granulator 16. A detailed view, i.e. a detailed side view and a cross-sectional view, of the design of the extruder screws 24 in the homogenization zone 48 is depicted in
(22) It should be acknowledged, that the dimensions, i.e. the lengths of the different zones 34, 38, 40, 42, 44, 46, 48 of the extruder screws 24 as well as the design of the different zones 34, 38, 40, 42, 44, 46, 48 of the extruder screws 24 may be varied as needed in dependence on the properties of the dry base powder, the slurry and the slurry/base powder mixture. Further, the extruder screws 24 may be cooled, at least in the region of the first and the second granulation zone 40, 44, e.g. by means of cooling channels provided in a housing of the granulator 16.
(23) The slurry/base powder mixture exiting the granulator 16 via the outlet port 32 is dried by means of a continuous or semi-continuous dryer 50. In particular, the dryer 15 is designed in the form of a fluid bed dryer. A drying temperature for drying the slurry/base powder mixture is higher than the evaporation temperature of the liquid contained in the slurry and may be between 50 and 75° C., in particular between 60 and 70° C. A drying time for removing 95% of the liquid contained in the granules exiting the granulator 16 does not exceed 35 minutes, in particular does not exceed 20 minutes, and preferably does not exceed 12 minutes. Typical dried granule sizes vary from 200 to 1000 μm.
(24) The granules obtained via the above-described method may be suitable for direct oral dosage or may be intended to be filled into capsules. Preferably, however, the granules are compacted so as to form tablets.
EXAMPLE 1
(25) A granulation process with the colorant “Opadry Basic Lack Yellow” as surrogate for a drug substance was performed using the process parameters summarized in table 1.
(26) TABLE-US-00001 TABLE 1 Example 1: a colorant as surrogate for a drug substance Solid feed composition Slurry feed composition Concentration Concentration Material (% w/w) Material (% w/w) Lactose milled 60 Opadry Basic 20 Lack Gelb Cellulose MK GR 30 Water 80 Glyceryl behenate 10 Equipment setup Twin screw granulator type: Thermo Fisher 16 MM Pharma Screw speed: 200 rpm Solid feed rate: 1.00 kg/h Slurry feed rate: 0.25 kg/h Temperature 13-15° C. in all zones
(27) For the preparation of a slurry containing the colorant, the suspending agent water was mixed with the colorant until the desired concentration indicated in table 1 was obtained. The slurry was constantly stirred for the preparation and thereafter for at least further 30 minutes using an overhead stirrer equipped with a four-blade agitator in order to maintain a uniform solution/suspension.
(28) Twin-screw wet granulation was performed on a co-rotating Pharma 16 mm twin-screw granulator (Thermo Scientific Pharma 16, Thermo Fisher Scientific, Karlsruhe, Germany). The twin-screw granulator was operated at a constant screw speed of 200 rpm. The temperature was kept constant at 13-15° C. in all zones. Powder components were directly fed into the twin-screw granulator from a continuous blender. The granulation liquid was dosed to the twin-screw granulator using a peristaltic pump (NM003BY11S12B, Netzsch Group, Selb, Germany).
(29) Satisfactory wet granules suitable for further processing by drying and compacting were obtained.
EXAMPLE 2
(30) A granulation process with the API LDK378 was performed using the process parameters summarized in table 2.
(31) TABLE-US-00002 TABLE 2 Example 2: LDK378 Solid feed composition Slurry feed composition Concentration Concentration Material (% w/w) Material (% w/w) MCC PH101 47.5 LDK378.DS 50.0 PVP K30 12.5 Water 30.0 Natrium CMC XL 10.0 Ethanol 20.0 Sodium Stearyl Fumerate 30.0 Equipment setup Twin screw granulator type: Thermo Fisher 11 MM Pharma Screw speed: 250 rpm Solid feed rate: 0.2 kg/h Slurry feed rate: 0.6 kg/h Temperature 20° C. in all zones
(32) For the preparation of a slurry containing the API, the API was dispensed in the suspending liquid until the desired concentration indicated in table 2 was obtained. No suspending agents were involved. The slurry was constantly stirred using an overhead stirrer equipped with a four-blade agitator in order to maintain a uniform solution/suspension.
(33) Twin-screw wet granulation was performed on a co-rotating Pharma 11 mm twin-screw granulator (Thermo Scientific Pharma 11, Thermo Fisher Scientific, Karlsruhe, Germany). The twin-screw granulator was operated at a constant screw speed of 250 rpm. The temperature was kept constant at 20° C. in all zones. Powder components were fed into the twin-screw granulator using a Brabender gravimetric feeder (DDW-MDO-MT-1, Brabender, Duisburg, Germany). The feeder mass flow rate was calibrated via the internal calibration mode. The solid mass flow rate has then been verified by a dynamic balance (K-Sampler K-SFS-24, Coperion K-Tron, Pitman, USA), in order to exclude process fluctuations due to powder flow instabilities. The granulation liquid was dosed to the twin-screw granulator (using a progressing cavity pump (NM003BY11S12B, Netzsch Group, Selb, Germany).
(34) Satisfactory wet granules suitable for further processing by drying and compacting were obtained.
EXAMPLES 3 to 5
(35) Granulation processes with the API Ibuprofen were performed using varying process parameters as summarized in tables 3 to 5.
(36) TABLE-US-00003 TABLE 3 Example 3: Ibuprofen (1) Solid feed composition Slurry feed composition Concentration Concentration Material (% w/w) Material (% w/w) MCC PH102 68.0 Ibuprofen 32.4-51.1 PVP K30 6.7 Polysorbate 80 0.2-0.3 Natrium CMC XL 21.4 Water 48.6-67.4 Magnesium stearate 4.0 Equipment setup Twin screw granulator type: Thermo Fisher 11 MM Pharma Screw speed: 250 rpm Solid feed rate: 0.19 kg/h Slurry feed rate: 0.59-0.93 kg/h Temperature 20° C. in all zones
(37) TABLE-US-00004 TABLE 4 Example 4: Ibuprofen (2) Solid feed composition Slurry feed composition Concentration Concentration Material (% w/w) Material (% w/w) MCC PH102 72.8 Ibuprofen 43.8 Natrium CMC XL 22.9 Sodium 1.8 pyrophosphate Magnesium stearate 4.3 PVP K30 1.8 Water 52.5 Equipment setup Twin screw granulator type: Thermo Fisher 11 MM Pharma Screw speed: 250 rpm Solid feed rate: 0.18 kg/h Slurry feed rate: 0.69 kg/h Temperature 20° C. in all zones
(38) TABLE-US-00005 TABLE 5 Example 5: Ibuprofen (3) Solid feed composition Slurry feed composition Concentration Concentration Material (% w/w) Material (% w/w) MCC PH102 68.0 Ibuprofen 44.6-53.3 PVP K30 6.7 Sodium 1.9-2.2 pyrophosphate Natrium CMC XL 21.3 Water 44.5-53.5 Magnesium stearate 4.0 Equipment setup Twin screw granulator type: Thermo Fisher 11 MM Pharma Screw speed: 250 rpm Solid feed rate: 0.19 kg/h Slurry feed rate: 0.56-0.67 kg/h Temperature 20° C. in all zones
(39) For the preparation of a slurry containing the API, the suspending liquid (water) was pre-weighed. The suspending agent sodium pyrophosphate or polysorbate was dissolved in the suspending liquid. For example 5, PVP K30 was then dissolved in the liquid. After that, dry API powder was added in small portions until the desired concentration indicated in tables 3 to 5 was obtained. The slurry was constantly stirred using an overhead stirrer equipped with a four-blade agitator in order to maintain a uniform solution/suspension.
(40) Twin-screw wet granulation was performed on a co-rotating Pharma 11 mm twin-screw granulator (Thermo Scientific Pharma 11, Thermo Fisher Scientific, Karlsruhe, Germany). The twin-screw granulator was operated at a constant screw speed of 250 rpm. The temperature was kept constant at 20° C. in all zones. Powder components were fed into the twin-screw granulator using a Brabender gravimetric feeder (DDW-MDO-MT-1, Brabender, Duisburg, Germany). The feeder mass flow rate was calibrated via the internal calibration mode. The solid mass flow rate has then been verified by a dynamic balance (K-Sampler K-SFS-24, Coperion K-Tron, Pitman, USA), in order to exclude process fluctuations due to powder flow instabilities. The granulation liquid was dosed to the twin-screw granulator (using a progressing cavity pump (NM003BY11S12B, Netzsch Group, Selb, Germany).
(41) Drying of wet granules was performed using a fluid bed dryer (Mini Glatt 5, Glatt, Binzen, Germany). The cone of the fluid bed dryer was filled with the same volume of wet granules for each experiment, which corresponded to a wet mass of approximately 120 g. The airflow was increased until appropriate fluidisation of the granules was observed. The granules were dried at an inlet air temperature of 65° C.
COMPARATIVE EXAMPLE
(42) Comparison was performed in detail for example 5. Traditional ibuprofen blend was fed to a co-rotating Pharma 11 mm twin-screw granulator (Thermo Scientific Pharma 11, Thermo Fisher Scientific, Karlsruhe, Germany). Therefore, all solid components were fed to the granulator as a dry powder blend. As granulation liquid, only water was added. The formulations of ibuprofen blend and ibuprofen suspension feed were quanitatively and qualitatively similar for L/S 0.5. The total solid mass flow rate (ibuprofen and excipients combined) was kept constant at 500 g/h, independent of whether the ibuprofen was dosed with the blend or as suspension (i.e. solids processed via the dry blend plus solids processed via the granulation liquid was equal to 500 g/h). The screw speed was 250 rpm, the temperature in all zones 20° C.
(43) Drying of the granules was performed using a fluid bed dryer (Mini Glatt 5, Glatt, Binzen, Germany). The cone of the fluid bed dryer was filled with the same volume of wet granules for each experiment, which corresponded to a wet mass of approximately 120 g. The airflow was increased until appropriate fluidisation of the granules was observed. The granules were dried at an inlet air temperature of 65° C.
(44) Characterization of the Granules
(45) In order to study the impact of the adapted granulation process on the compaction behaviour of the granules and on compact properties, the granules obtained according to example 5 and the granules obtained according to the comparative example were compacted so as to form tablets and characterized as follows.
(46) Prior compaction, granules were sieved through a 1 mm mesh. Round flat face compacts (11.28 mm diameter, compact mass 500 mg) were manufactured, using a fully instrumented compaction simulator equipped with a hopper (Stylcam® 200R, Medel-pharm, Beynost, France). A FETTE P1200 was mimicked. Varying compaction pressures (60 MPa, 100 MPa and 140 MPa) were applied with a dwell time of 13 ms.
(47) Compacts were characterised by measuring compact height and diameter, out-of-the-die porosity, crushing force and dissolution time for ibuprofen. The compact height and diameter were assessed immediately after compaction, using callipers (Traceable®, VWR, Radnor, USA). The out-of-the-die porosity was calculated for 10 compacts produced at each compaction pressure by using the true density, the compact height and diameter, assessed immediately after compaction. The crushing force was measured (Pharmatron Multitest 50, Pharmatron, Thun, Switzerland) for 10 compacts produced at each compaction pressure. The dissolution time of compacts manufactured at 100 MPa was measured according to the USP for ibuprofen tablets (n=3). A paddle apparatus has been used (AT7 Smart double bath, Sotax, Aesch, Switzerland). After 60 min, the paddle speed was increased from 50 to 200 rpm and after 75 min, a final measurement cycle was performed. During a measurement cycle the media was pumped from the dissolution vessel to an in-line UV-spectrometer (Lambda 25, PerkinElmer instruments, Schwerzenbach, Switzerland) and back again to the vessel. UV-measurements were performed at a wavelength of 222 nm using a 1 mm measuring cell.
(48) The compaction process of the dried granules from twin-screw wet granulation with API suspension feed has been compared to the compaction process of the dried granules from traditional API blend feed using force-displacement-curves. For dried granules of both processes, the force-displacement-curves from the compaction were almost overlaying, see
(49) This observation is in line with the trend found in the data of the tensile strength. The tensile strength has been observed consistently higher for the Ibuprofen slurry feed than for the Ibuprofen powder blend feed (1.1 versus 0.9 MPa, 1.8 versus 1.4 MPa, 1.9 versus 1.7 MPa, for 60, 100 and 140 MPa compaction pressure for Ibuprofen slurry feed versus Ibuprofen powder blend feed), see
(50) The dissolution rate for Ibuprofen compacts manufactured from the granules from the Ibuprofen slurry feed approach was slightly slower than for the compacts manufactured from granules from the Ibuprofen powder blend feed approach, see